SHL exhibiting at Drug Delivery Partnerships 2017

2107ddp Ad 170124 News Page 800x480

SHL Group is proud to exhibit at Drug Delivery Partnerships in Palm Beach Gardens, Florida on February 7-9, 2017.

SHL will showcase its vast range of drug delivery products, including the Molly® family of devices that can accommodate various pharma and biotech companies’ requirements, from high volume to connectivity. Another focus for 2017 will be SHL’s state-of-the-art devices for high viscosity solutions represented by several new offers.

As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow.

To find out more about SHL’s latest research and innovation, comprehensive capabilities, and device commercialization solutions, talk to one of the SHL representatives in Booth #406.

The Drug Delivery Partnership will take place on February 7-9, 2017 in the PGA National Resort & Spa, Palm Beach Gardens, Florida, USA.

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery systems such as autoinjectors, pen injectors and advanced inhaler systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.

With locations in Switzerland, Taiwan, Sweden, and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

For additional information, visit

Media contact:   

Related News